# Impact of Adverse Metabolic Factors on the Burden of Chronic Kidney Disease in the Chinese Population ≥ 20 Years Old, 1990–2019

**Authors:** Jiali Huang, Yiwei He, Fan Yang

PMC · DOI: 10.1002/dmrr.70143 · Diabetes/Metabolism Research and Reviews · 2026-02-27

## TL;DR

This study examines how metabolic factors like high blood pressure and obesity have contributed to chronic kidney disease in Chinese adults from 1990 to 2019.

## Contribution

The study quantifies the impact of adverse metabolic factors on CKD burden in China over nearly three decades.

## Key findings

- High systolic blood pressure was the leading contributor to CKD burden in 2019.
- The attributable mortality rate for CKD increased by 0.55% annually from 1990 to 2019.
- High BMI showed the fastest increase in attributable mortality burden over time.

## Abstract

To quantify temporal trends in chronic kidney disease (CKD) burden attributable to adverse metabolic risk factors among Chinese adults aged ≥ 20 years during 1990–2019.

We used Global Burden of Disease Study 2019 (GBD 2019) estimates for China to assess five CKD causes (CKD due to type 1 diabetes, type 2 diabetes, hypertension, glomerulonephritis, and other/unspecified causes) and three metabolic risks (high systolic blood pressure (SBP), high body mass index (BMI), and high fasting plasma glucose (HFPG)). Outcomes were deaths and disability‐adjusted life years (DALYs) (numbers and rates per 100,000), stratified by sex and 13 age groups. Joinpoint regression was used to estimate annual percent change (APC) and average annual percent change (AAPC) in rates from 1990 to 2019.

In 2019, the mortality rate for CKD attributable to these metabolic risks was 6.87 per 100,000, and total attributable DALYs were 4201 (thousand). Hypertensive nephropathy had the largest attributable burden (mortality 2.5/100,000; DALY rate 59.2/100,000), followed by CKD due to type 2 diabetes. From 1990 to 2019, the overall attributable CKD mortality rate increased (AAPC = 0.55%) while the DALY rate decreased slightly (AAPC = −0.27%). High SBP remained the leading contributor to attributable burden in 2019, whereas high BMI showed the fastest increase in attributable mortality burden over time. Attributable burden increased steeply with age and was higher in males than in females.

High SBP remains a major driver of CKD burden in China, but the rapidly rising high‐BMI‐attributable burden highlights the need for integrated prevention focused on blood pressure control and obesity prevention, particularly among older adults and men.

## Linked entities

- **Diseases:** chronic kidney disease (MONDO:0005300), type 1 diabetes (MONDO:0005147), type 2 diabetes (MONDO:0005148), glomerulonephritis (MONDO:0002462)

## Full-text entities

- **Genes:** APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, PCLAF (PCNA clamp associated factor) [NCBI Gene 9768] {aka KIAA0101, L5, NS5ATP9, OEATC, OEATC-1, OEATC1}
- **Diseases:** obesity (MESH:D009765), overweight (MESH:D050177), nephritis (MESH:D009393), metabolic disease (MESH:D008659), Hypertensive nephropathy (MESH:C563161), cardiometabolic disease (MESH:D024821), Disease (MESH:D004194), diabetes (MESH:D003920), AAPC (MESH:D009402), CKD (MESH:D051436), kidney disease (MESH:D007674), type 2 diabetes (MESH:D003924), IHME (MESH:D000072861), type 1 diabetes (MESH:D003922), diabetic CKD (MESH:D003928), albuminuria (MESH:D000419), glomerulonephritis (MESH:D005921), hypertension (MESH:D006973), deaths (MESH:D003643), end-stage renal disease (MESH:D007676), GBD 2019 (MESH:D000086382), infection (MESH:D007239), cardiovascular disease (MESH:D002318), GBD (MESH:D001037)
- **Chemicals:** fat (MESH:D005223), glucose (MESH:D005947), HFPG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12949367/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12949367/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12949367/full.md

---
Source: https://tomesphere.com/paper/PMC12949367